GU Cancers Symposium 2013 - High-risk prostate cancer treated with pelvic radiotherapy and 36 vs 18 months of androgen blockade: Results of a phase III randomized trial

ORLANDO, FL, USA (UroToday.com) - Presented by Abdenour Nabid,¹ Nathalie Carrier,¹ André-Guy Martin,² Jean-Paul Bahary,³ Luis Souhami,⁴ Marie Duclos,⁴ François Vincent,⁵ Sylvie Vass,⁶ Boris Bahoric,⁷ Robert Archambault,⁸ Céline Lemaire⁹ at the 2013 Genitourinary Cancers Symposium - February 14 - 16, 2013 - Rosen Shingle Creek - Orlando, Florida USA

This is an embedded<a href="http://office.com" target="_blank">Microsoft Office</a>presentation, powered by<a href="http://office.com/webapps" target="_blank">Office Web Apps</a>.

Read highlights of this presentation by a UroToday.com medical writer.

¹Centre Hospitalier Universitaire de Sherbrooke, CA, ²Centre Hospitalier Universitaire de Québec, CA, ³Centre Hospitalier Universitaire de Montréal, CA, ⁴Centre Universitaire de Santé McGill, CA, ⁵Centre Hospitalier Régional de Trois-Rivières, CA, ⁶Centre de Santé et Services Sociaux de Chicoutimi, CA, ⁷Hôpital Général Juif de Montréal, CA, ⁸Hôpital de Gatineau, CA, ⁹Hôpital Maisonneuve-Rosemont de Montréal, CA

View Full 2013 GU Cancers Symposium Coverage

Login